<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The b and c variants of fibroblast growth factor receptor 2 (FGFR2) differ in sequence, binding specificity, and localization </plain></SENT>
<SENT sid="1" pm="."><plain>Fgfr2b, expressed in epithelia, is required for limb outgrowth and branching morphogenesis, whereas the mesenchymal Fgfr2c variant is required by the osteocyte lineage for <z:mpath ids='MPATH_458'>normal</z:mpath> skeletogenesis </plain></SENT>
<SENT sid="2" pm="."><plain>Gain-of-function mutations in human FGFR2c are associated with <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> syndromes </plain></SENT>
<SENT sid="3" pm="."><plain>To confirm and extend this evidence, we introduced a Cys342Tyr replacement into Fgfr2c to create a gain-of-function mutation equivalent to a mutation in human <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e> and Pfeiffer syndromes </plain></SENT>
<SENT sid="4" pm="."><plain>Fgfr2c(C342Y/)(+) heterozygote mice are viable and fertile with shortened face, <z:hpo ids='HP_0000520'>protruding eyes</z:hpo>, premature fusion of cranial sutures, and enhanced Spp1 expression in the calvaria </plain></SENT>
<SENT sid="5" pm="."><plain>Homozygous mutants display multiple <z:e sem="disease" ids="C0003881,C0003090" disease_type="Disease or Syndrome;Acquired Abnormality;Therapeutic or Preventive Procedure" abbrv="">joint fusions</z:e>, <z:hpo ids='HP_0000175'>cleft palate</z:hpo>, and trachea and lung defects, and die shortly after birth </plain></SENT>
<SENT sid="6" pm="."><plain>They show enhanced Cbfa1/Runx2 expression without significant change in chondrocyte-specific Ihh, PTHrP, Sox9, Col2a, or Col10a gene expression </plain></SENT>
<SENT sid="7" pm="."><plain>Histomorphometric analysis and bone marrow stromal cell culture showed a significant increase of osteoblast progenitors with no change in osteoclastogenic cells </plain></SENT>
<SENT sid="8" pm="."><plain>Chondrocyte proliferation was decreased in the skull base at embryonic day 14.5 but not later </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that long-term aspects of the mutant phenotype, including <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo>, are related to the Fgfr2c regulation of the osteoblast lineage </plain></SENT>
<SENT sid="10" pm="."><plain>The effect on early chondrocyte proliferation but not gene expression suggests cooperation of Fgfr2c with Fgfr3 in the formation of the cartilage model for endochondral bone </plain></SENT>
</text></document>